Lung Diseases, Interstitial
85
14
15
47
Key Insights
Highlights
Success Rate
85% trial completion
Published Results
18 trials with published results (21%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.4%
8 terminated out of 85 trials
85.5%
-1.1% vs benchmark
14%
12 trials in Phase 3/4
38%
18 of 47 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 47 completed trials
Clinical Trials (85)
H01 in Adults With Interstitial Lung Disease (The SOLIS Study)
Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease
Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan
NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases
A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease
Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients
Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise
BPF Genetics of ILD Study
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS)
Lung Cancer Screening CT for Firefighters
A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON)
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan
Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease
Database for Interstitial Lung Disease
Cough Capture as a Portal Into the Lung
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases
Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors
Dorothy P. and Richard P. Simmons Center for ILD Research Registry